TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$201.3 Million

Pacific Biosciences of California

Follow-on Offering

Bookrunner, January 2023

Pacific Biosciences of California
Follow-On Offering

Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“PacBio” or the “Company”) is a premier life science technology company that is designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. PacBio’s products and technology under development stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include the Company’s existing HiFi long-read sequencing and its emerging SBB short-read sequencing technologies. PacBio’s products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. The Company’s focus is on providing its customers with advanced sequencing technologies with higher throughput and improved workflows that it believes will enable dramatic advancements in routine healthcare.